gdc-0973 and Demyelinating-Diseases

gdc-0973 has been researched along with Demyelinating-Diseases* in 1 studies

Other Studies

1 other study(ies) available for gdc-0973 and Demyelinating-Diseases

Article	Year
Demyelinating polyradiculoneuropathy under combined BRAF/MEK inhibitors. European journal of cancer (Oxford, England : 1990), 2017, Volume: 78 Topics: Antineoplastic Combined Chemotherapy Protocols; Azetidines; Brain Neoplasms; Demyelinating Diseases; Female; Guillain-Barre Syndrome; Humans; Indoles; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; MAP Kinase Kinase Kinases; Melanoma; Middle Aged; Piperidines; Polyradiculoneuropathy; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf; Skin Neoplasms; Sulfonamides; Vemurafenib	2017

Article

Year

Demyelinating polyradiculoneuropathy under combined BRAF/MEK inhibitors.

European journal of cancer (Oxford, England : 1990), 2017, Volume: 78

Topics: Antineoplastic Combined Chemotherapy Protocols; Azetidines; Brain Neoplasms; Demyelinating Diseases; Female; Guillain-Barre Syndrome; Humans; Indoles; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; MAP Kinase Kinase Kinases; Melanoma; Middle Aged; Piperidines; Polyradiculoneuropathy; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf; Skin Neoplasms; Sulfonamides; Vemurafenib

2017